Marvell Technology agreed on Monday 2 November to buy laser and optical-module maker Lumentum in an all-stock deal with an implied enterprise value of $115 billion, according to the companies' joint press release filed with the SEC. Investors sold both stocks: Marvell closed down 12.72% at $171.41 and Lumentum fell 18.59% to $684.40, while the PHLX Semiconductor index (SOX) lost 3.37% and the Nasdaq Composite 1.07%, according to StockAnalysis and Investing.com closing data.
Financial analyst Ruslan Averin reads the sell-off as a vote on the currency rather than on the strategy: the deal is paid entirely in Marvell shares, and the market has marked those shares down by almost a third since the talks leaked on Wednesday 28 October.
The terms: 4.5 Marvell shares for every Lumentum share
- Exchange ratio: fixed at 4.500 Marvell shares per Lumentum share, with no cash component, the press release says.
- Headline price: about $1,132 per Lumentum share, a premium of about 23.9% to the unaffected closes of Wednesday 28 October, when Marvell finished at $251.65 and Lumentum at $913.95. Reuters put the equity value at $102.54 billion.
- Ownership: Marvell holders keep about 67% of the combined company and Lumentum holders get about 33% on a fully diluted basis.
- Timing: closing is expected in the first half of calendar 2028, subject to both shareholder votes and regulatory approvals.
- Break fees: Marvell owes $5.8 billion if its board walks away or takes a rival offer, Lumentum owes $2.9 billion in the mirror case, and Marvell pays a $3.2 billion regulatory fee if antitrust or foreign-investment authorities block the deal, the Form 8-K shows.
- Economics: "line of sight" to more than $1 billion of annual run-rate cost synergies, mostly in cost of goods, and accretion to Marvell's non-GAAP earnings per share in the first year after closing, the companies say.
Matt Murphy stays chairman and CEO. "AI infrastructure is undergoing a fundamental architectural shift toward optical connectivity, creating an opportunity that comes along once in a generation," Murphy said in the release.
There is no new debt: Marvell held $3.93 billion of cash, according to StockAnalysis, so a cash deal of this size was never realistic.
Why Marvell wants the lasers
Copper links inside AI data centres are hitting physical limits, and the industry is moving to optics, the release argues. Marvell brings DSPs, switching and custom AI chips; Lumentum brings high-power lasers, transceivers, optical circuit switches and indium phosphide wafer fabs, which Marvell's investor slides call the world's largest InP capacity. The pitch is "co-design" of electrical and optical parts, including co-packaged optics (CPO).
Lumentum's own fiscal first-quarter report, released the same day, shows why the price is high. Revenue rose 136.5% from a year earlier to $1.26 billion, the non-GAAP operating margin reached 42.3%, and the company won its second major NPO/CPO contract "backed by purchase commitments exceeding $5 billion". It guided December-quarter revenue to $1.575–1.625 billion, above the $1.48 billion LSEG consensus cited by Reuters.
On the slides, the pro forma company has $17.7 billion of annualised revenue ($12.6 billion from Marvell, $5.1 billion from Lumentum) and a target market of $550 billion by 2030. Nvidia invested $2 billion in each company earlier this year, Reuters reported, so both sit inside the same supplier network described in my Nvidia Q2 FY2027 review.
The verdict: about $91 billion of market value gone in four sessions
| Stock / index | Close 28 Oct | Close 2 Nov | Change on 2 Nov | Since 28 Oct |
|---|---|---|---|---|
| Marvell (MRVL) | $251.65 | $171.41 | −12.72% | −31.9% |
| Lumentum (LITE) | $913.95 | $684.40 | −18.59% | −25.1% |
| Coherent (COHR) | $239.59 | $199.95 | −4.93% | −16.5% |
| Broadcom (AVGO) | $351.81 | $322.23 | −1.18% | −8.4% |
| Nvidia (NVDA) | $215.38 | $202.06 | −1.26% | −6.2% |
| SOX index | 11,684.0 | 10,328.3 | −3.37% | −11.6% |
| Nasdaq Composite | 26,549.85 | 25,164.31 | −1.07% | −5.2% |
Sources: StockAnalysis (stocks), Investing.com (indices); changes since 28 October are my calculation.
Marvell fell 13.24% on Thursday 29 October and 10.05% on Friday 30 October before Monday's drop. Using StockAnalysis share counts, that cut about $70 billion from Marvell and about $21 billion from Lumentum, roughly $91 billion together.
The key arithmetic: at Monday's close, 4.5 Marvell shares were worth $771.35, not $1,132. The "23.9% premium" has turned into a value 15.6% below Lumentum's own unaffected price. And Lumentum, at $684.40, trades about $87 below even that figure, a gap of 12.7% that measures how much doubt the market attaches to the deal closing on time.
The sell-off also landed on a weak tape. The SOX had already fallen 7.20% on Friday 30 October, the day of Intel's 28.6% plunge on a weak outlook, and investors were still digesting the Big Tech capex stress test.
What $115 billion buys
By my calculation, $115 billion is about 22.5 times Lumentum's annualised first-quarter revenue of $5.1 billion and about 18 times the annualised midpoint of its December-quarter guidance. On profit, the first quarter's non-GAAP operating income of about $534 million annualises to $2.1 billion, so the price is roughly 54 times that, or about 40 times if the guided 45–46% margin holds on $1.6 billion of revenue.
That is a price for a business at a cyclical high. TD Cowen's argument, as reported by Investing.com, is exactly that: consensus implies an optical transceiver market of about $100 billion in 2027 against the broker's own $47 billion forecast, so the deal may be struck "near the peak of an optical mini-cycle".
Analysts: two downgrades and one defender
- TD Cowen (Sean O'Loughlin) cut Marvell to Hold from Buy and halved its target to $175 from $350, expecting mid-single-digit EPS dilution in 2028. "Our downgrade is driven primarily by our negative view of the transaction itself in terms of structure and timing," the note said, Investing.com reported.
- BofA Securities (Vivek Arya) cut Marvell to Neutral from Buy, target $225 from $400, arguing that $1 billion of cost savings does not offset about 50% share dilution and flagging a long regulatory process, according to Investing.com.
- William Blair kept its Outperform rating, Investing.com reported; B. Riley downgraded Lumentum on the deal terms.
- Axel Rudolph of IG Group told Reuters "this is an enormous bet, and investors are right to ask whether Marvell is paying too much".
The regulatory clock: Washington and Beijing
The Form 8-K requires expiry of the US Hart-Scott-Rodino waiting period plus "certain other required regulatory approvals", including foreign-investment reviews. The outside date is 1 November 2027, extendable in steps to 1 August 2028 if approvals are pending.
China is the obvious risk. Lumentum competes with China's Zhongji Innolight, and a proposed US ban on new Chinese optical transceivers would shift demand to American suppliers, Reuters noted. A Reuters Breakingviews column on Monday 2 November was headlined "China adds latency to Marvell's optical mega-deal". The precedent is Intel's planned purchase of Tower Semiconductor, abandoned in 2023 after China's market regulator, SAMR, did not clear it in time.
Scenario logic for MRVL
Base case: Marvell trades as a deal currency with an overhang until the S-4 and shareholder votes, tracking the SOX, which BofA said had fallen 19% in a month.
Bull case: Lumentum delivers about $1.6 billion in the December quarter, more CPO contracts are announced, and Marvell's own report confirms the preliminary third-quarter revenue it reiterated on Monday. A shrinking spread would show the market accepting the logic, as with TSMC's AI demand guidance.
Bear case: the optical cycle peaks before closing, China's review drags toward the August 2028 limit, or a shareholder vote fails. That is the scenario from the September chip sell-off, with an added $3.2 billion bill if regulators block the deal.
I would watch the spread between 4.5 Marvell shares and Lumentum's price more than either stock alone: it is the market's daily estimate of whether this deal closes. The wider question is the AI capex and revenue gap: a $115 billion bet on optics needs data-centre budgets to keep rising into 2028.
What to watch next
- Tuesday 17 November: Nvidia's fiscal third-quarter report, per the StockAnalysis calendar.
- Tuesday 1 December (estimated): Marvell's full fiscal third-quarter results.
- Late December: end of Lumentum's fiscal second quarter, guided at $1.575–1.625 billion of revenue.
- Coming weeks: filing of the joint S-4 and the Hart-Scott-Rodino notification.
- 1 November 2027: the merger agreement's first outside date, extendable to 1 August 2028.
Related: Big Tech's AI capex stress test, Intel's plunge on a weak Q4 outlook and the Nasdaq's worst week of October